1) Rinke de Wit TF, Tsegaye A, Wolday D, Hailu B, Aklilu M, Sanders E, Hagos M, Kliphuis A, Pollakis G, Krol A, Geskus R, Miedema F, Goudsmit J, Coutinho R, Fontanet AL. Primary HIV-1 subtype C infection in Ethiopia. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology , 2002;30:463-70. Abstract.

2) Tsegaye A, Rinke de Wit TF, Mekonnen Y, Beyene A, Aklilu M, Messele T, Abebe A, Coutinho RA, Sanders E, Fontanet AL. Decline in HIV-1 and syphilis prevalence among young antenatal care attenders in Addis Ababa: results from sentinel surveillance, 1995-2001. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 2002;30:359-62. Abstract.

3) Ayele W, Nokes DJ, Abebe A, Messele T, Dejene A, Enquselassie F, Rinke de Wit TF, Fontanet AL. Higher prevalence of anti-HCV antibodies among HIV-positive compared to HIV-negative inhabitants of Addis Ababa, Ethiopia. Journal of Medical Virology 2002 ;68 :12-17. Abstract.

4) Mekonnen Y, Jegou R, Coutinho RA, Nokes J, Fontanet A. Demographic impact of AIDS in a low fertility urban African setting : projection for Addis Ababa, Ethiopia. Journal of Health Population and Nutrition 2002;20:120-9. Abstract.

5) Sahlu T, Rinke de Wit TF, Tsegaye A, Mekonnen Y, Beyene A, Hailu B, Coutinho RA, Fontanet A. Low incidence of syphilis among factory workers in Ethiopia: effect of an intervention based on education and counselling. Sexually Transmitted Infections 2002 ;78 :123-6. Abstract.

6) Eyob G, Gebeyhu M, Goshu S, Girma M, Lemma L, Fontanet A. Increase in tuberculosis incidence among the staff working at the Tuberculosis Demonstration and Training Center in Addis Ababa, Ethiopia: a retrospective cohort study (1989-1998). The International Journal of Tuberculosis and Lung Disease 2002;6:85-88. Abstract.

7) Meles H, Wolday D, Fontanet A, Tsegaye A, Girma M, Aklilu M, Sanders E, Rinke de Wit TF. Indeterminate HIV-1 Western blot profiles in Ethiopians with discordant screening assays. Clinical and Diagnostic Laboratory Immunology, 2002;9:160-3. Abstract.

8) Mihret W, Rinke de Wit TF, Petros B, Mekonnen Y, Tsegaye S, Wolday D, Beyene A, Aklilu M, Sanders E, Fontanet AL. Herpes simplex virus type 2 seropositivity among urban adults in Africa: results from two cross-sectional surveys in Addis Ababa, Ethiopia. Sexually Transmitted Diseases 2002;29:175-181. Abstract.

9) Dorenbaum, C.K Cunningham, R.D Gelber, M. Culnane, L. Mofenson, P. Britto, C. Rekacewicz, M.L. Newell for the European Collaborative Study, J.F. Delfraissy, B. Cunningham-Schrader, M. Mirochnick, J.L. Sullivan for the international PACTG 316 team. A Randomized Trial of Addition of Two-Dose Intrapartum/Newborn Nevirapine to Standard Antiretroviral Therapy to Reduce Perinatal Human Immunodeficiency Virus type-1 Transmission: Pediatric AIDS Clinical Trials Group 316, JAMA 2002;288:189-198. Abstract.

10) C.K Cunningham, M.L. Chaix, C. Rekacewicz, P. Britto, C. Rouzioux, R.D. Gelber, A. Dorenbaum, J.F. Delfraissy, B. Bazin, L. Mofenson and J.L. Sullivan for the PACTG 316 team. Development of resistance mutations in women on standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal HIV-1 transmission: a substudy of Pediatric AIDS Clinical Trials Group protocol 316. JID 2002;186:181-188; Abstract.

11) M. Saman, L. S. Kruy, P. Glaziou, C. Rekacewicz, C. Leng, J.F. Delfraissy. Feasibility of antenatal and late HIV testing in pregnant women, in Phnom Penh Cambodia: preliminary Results of the PERIKAM/ANRS1205 study. Research Letter AIDS 2002;16:950-951. Abstract.

12) Meynard JL, Vray M, Morand-Joubert L, Race E, Descamps D, Peytavin G, Matheron S, Lamotte C, Guiramand S, Costagliola D, Brun-Vezinet F, Clavel F, Girard PM, for the Narval Trial Group. Phenotypic and genotypic resistance testing for choosing antiretroviral therapy after treatment failure : a randomized trial AIDS. 2002;16:727-36. Abstract.

13) Samama CM, Vray M, Barre J, Fiessinger JN, Rosencher N, Lecompte T, Potron G, Basile J, Hull R, Desmichels D; SACRE Study Investigators. Extended venous thromboembolism prophylaxis after total hip replacement: a comparison of low-molecular-weight heparin with oral anticoagulant. Arch Intern Med 2002;162:2191-6. Abstract.

14) Sangeetha Madhavan; Nicholas Townsend; Stephen Tollman; Michel Garenne. Children’s residence patterns and educational attainment in rural South Africa. Population Studies, 2002;56(2): [July 2002].

15) Garenne M. Sex ratios at birth in African populations: a review of survey data. Human Biology, 2002;74:889-900. Abstract.

16) Garenne M. The political economy of an urban famine: Antananarivo 1985-1986. IDS Bulletin, 2002;33:55-62. Abstract

Mis à jour le 10/06/2014


Unité d'Epidémiologie des Maladies Emergentes

Institut Pasteur
25-28 rue du Dr Roux
75724 Paris Cedex 15

Tél : +33 (0)1 40 61 37 66
Fax: +33 (0)1 45 68 88 76

Où nous trouver ?